[The use of therapeutic/prophylactic dragee "honey laminolact" in radiotherapy of uterine tumors].
The study deals with the effect of a newly-developed food product--Honey Laminolact, containing live lactic acid bacteria, amino acids, trace elements, fruit pectine and immunomodulators-on the degree of response to radiation in 44 patients who received radiotherapy for uterine tumors. It was shown to lower response of the intestinal tract to radiation when the small pelvis was exposed.
Smirnova
I I
II
Research Institute of Experimental Medicine, Russian Academy of Medical Sciences, St. Petersburg.
Filatova
E I
EI
Suvorov
A N
AN
Bylinskaia
E N
EN
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D004338:Drug Combinations; D004760:Enterocolitis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007778:Lactobacillus; D007958:Leukocyte Count; D008875:Middle Aged; D019936:Probiotics / Q000627:therapeutic use*; D011832:Radiation Injuries / Q000188:drug therapy* / Q000517:prevention & control; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D011878:Radiotherapy / Q000009:adverse effects; D016896:Treatment Outcome; D014594:Uterine Neoplasms / Q000532:radiotherapy*
D000276:Adjuvants, Immunologic; D004338:Drug Combinations; D005765:Gastrointestinal Agents; D011837:Radiation-Protective Agents
Opyt primeneniia lechebno-profilakticheskogo drazhe "laminolakt medovyĭ" pri luchevom lechenii bol'nykh rakom tela matki.